These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3383549)

  • 61. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ; Ponticas S; Shungu DL; Guerriero S
    Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combination amdinocillin and cefoxitin therapy of multiply-resistant Serratia marcescens urinary tract infections.
    Ward TT; Amon MB; Krause LK
    Am J Med; 1983 Aug; 75(2A):85-9. PubMed ID: 6311011
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant gram-negative bacteria.
    Mehtar S; Drabu YJ; Blakemore PH
    J Antimicrob Chemother; 1990 Jun; 25(6):915-9. PubMed ID: 2164513
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Traub WH; Leonhard B
    Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
    Alford RH
    Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of aminoglycosides in face of introduction of new beta-lactam antibiotics in treatment of nosocomial infection.
    McGowan JE; McClellan DB; Irwin PS
    Infect Control; 1983; 4(6):440-3. PubMed ID: 6558023
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1632-5. PubMed ID: 3075433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Temocillin. In vitro antibacterial activity.
    Slocombe B; Cooper CE; Griffin KE; White AR
    Drugs; 1985; 29 Suppl 5():49-56. PubMed ID: 3849425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inducing capacity of the combinations mecillinam-ampicillin and mecillinam-ceftazidime in comparison with the capacity of the compounds administered separately.
    Stobberingh EE; van Boven CP
    Chemotherapy; 1987; 33(2):97-102. PubMed ID: 3552473
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Combination effect of fosfomycin to beta-lactam, aminoglycoside, and macrolide antibiotics against clinical isolates of Klebsiella pneumoniae].
    O'Hara K; Nakamura A; Shigenobu F; Chen J; Sawai T
    Jpn J Antibiot; 1997 Aug; 50(8):704-10. PubMed ID: 9339396
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillin.
    Sanders CC; Sanders WE; Goering RV; McCloskey RV
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1164-8. PubMed ID: 3498436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activity of cefazolin against dense populations of enterobacteria.
    Greenwood D; Chan-Teoh CH; O'Grady F
    Antimicrob Agents Chemother; 1975 Feb; 7(2):191-5. PubMed ID: 1137370
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
    Tindula RJ; Ambrose PJ; Harralson AF
    Drug Intell Clin Pharm; 1983 Dec; 17(12):906-8. PubMed ID: 6653408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibiotic-resistant gram-negative bacteria in a virtually closed water reticulation system.
    Mulamattathil SG; Esterhuysen HA; Pretorius PJ
    J Appl Microbiol; 2000 Jun; 88(6):930-7. PubMed ID: 10849168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.